A Phase 2, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Four-Arm Trial to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo for the Treatment of Abdominal Pain in Patients With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D).

Trial Profile

A Phase 2, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Four-Arm Trial to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo for the Treatment of Abdominal Pain in Patients With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D).

Suspended
Phase of Trial: Phase II

Latest Information Update: 16 Jul 2010

At a glance

  • Drugs RVX 100 (Primary)
  • Indications Abdominal pain; Irritable bowel syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 May 2010 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
    • 13 May 2010 Planned end date changed from 1 Oct 2010 to 1 Mar 2011 as reported by ClinicalTrials.gov.
    • 22 Apr 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top